Navigation Links
Coronary heart disease bids Adieu

According to a report in The Journal of the American Medical Association. Coronary heart disease is reduced by lowering plasma homocystine levels with a diet supplement of folic acid alone or in combination with cyanocobalamin.

Dr.Tice from the University of California at San Francisco and colleagues used the Coronary Heart Disease Policy Model to assess the cost effectiveness of lowering levels of homocystine through grains fortified with folic acid and with cyanocobalamin and folic acid among participants in the third National Health and Nutrition Examination Survey.//

Their model predicted that grains fortified with folic acid could reduce myocardial infarction by 13% in men and 8% in women, with comparable reductions in death from CHD. "Using our most conservative assumptions, the estimated reductions in annual CHD mortality rates were 1% to 3%," the researchers report.

In addition to consuming fortified grains, if all patients with CHD received 1 mg of folic acid plus 0.5 mg of cyanocobalamin per day, the model projected that there would be approximately 310,000 fewer deaths and lower CHD-related costs over 10 years, compared with consuming folic-acid-fortified grains alone.

Over the same 10-year period, the model also predicted that for men 45 years of age or older without CHD, folic acid and cyanocobalamin supplementation given in addition to fortified grains would save more than 300,000 quality adjusted life-years. In addition, for women 55 years of age and older without CHD, the same strategy would result in 140,000 quality adjusted life-years saved, Dr.Tice's group calculated.


'"/>




Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Coronary stent leads to complications
3. Older Men Surviving Coronary Bypasses
4. The Link Between Oxidized Phospholipids And Coronary Artery Disease
5. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
6. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Children Are At The Risk Of Inheriting Coronary Disease
9. Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival
10. Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease
11. Microcirculation in Eye May Indicate Coronary Heart Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... Mich. (PRWEB) , ... March ... ... and Manufacturer Alliance (GRMA) is growing as it continues developing an ANSI-approved, ... supplement industry. The organization, which plans to publish the first ANSI-approved GMP ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... Los Angeles, CA (PRWEB) , ... March 28, 2017 , ... ... “wake-up call” asking the American public to take the Diabetes Risk Test to find ... the event, the Los Angeles World Airports will light up the evening sky by ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 2.87% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:3/29/2017)... March 29, 2017  Spiral Therapeutics, Inc. today ... Bionure Farma, S.L. for the worldwide exclusive rights ... in the field of otolaryngology for aggregate payments ... The agreement provides Spiral with the option ... differentiated product profile. Under the terms of the ...
(Date:3/29/2017)... -- NetworkNewsWire Editorial Coverage  ... There are a number of ... but economic arguments also favor its legalization. The benefits include ... However, to legalize and regulate marijuana requires an ecosystem of ... ( SING Profile ), American Cannabis Company (OTC: AMMJ), Kush ...
Breaking Medicine Technology: